Abstract:Objective To investigate the expression of serum miR-92a in Hirschsprung's disease (HD) and its role in regulation of CDX2 and inhibition of enteric neural stem cells (ENSCs). Methods Serum miR-92a was detected by real-time PCR in 16 patients with Hirschsprung's disease from January 2013 to December 2015 in Yishui Central Hospital of Linyi. ENSCs were collected from SD rats of gestational day 15, and identified by immunological method. ENSCs were over-expressed with miR-92a using lipofectin transfection after being separated by magnetic activated cell sorting, and then the expression of CDX2 was valued by real-time PCR and Western blot. The cell proliferation activity was determined by MTT method. Results The level of serum miR-92a mRNA in the patients with Hirschsprung's disease was higher than that in the control group (t = 12.661, P = 0.000). Nestin was positively stained in the ENSCs of early culture stage, which also had the potential to differentiate into double positive cells with Tuj-1 and glial fibrillary acidic protein (GFAP). The over-expression of miR-92a in the ENSCs increased the level of CDX2 mRNA (F = 47.212, P = 0.000) and protein (F = 48.793, P = 0.000) compared to the control group. Cell proliferation activity was inhi-
bited at 24, 48 and 72 h after transfection. Conclusions miR-92a may promote the occurrence and development of HD through up-regulation of CDX2 and consequent inhibition of ENSC proliferation.